Denosumab-induced hypocalcaemia in metastatic castrate-resistant prostate cancer
Denosumab is a fully human MAB that acts as a potent anti-resorptive by inhibiting activation of osteoclasts by inhibiting the receptor activator of nuclear factor-kappa B (RANK) ligand. Hypocalcaemia has been reported as one of the serious adverse sequelae of use of denosumab. We present a case of...
সংরক্ষণ করুন:
| প্রধান লেখক: | , , |
|---|---|
| বিন্যাস: | Artigo |
| ভাষা: | Inglês |
| প্রকাশিত: |
Bioscientifica
2019-12-01
|
| মালা: | Endocrinology, Diabetes & Metabolism Case Reports |
| অনলাইন ব্যবহার করুন: | https://doi.org/10.1530/EDM-19-0063 |
| ট্যাগগুলো: |
কোনো ট্যাগ নেই, প্রথমজন হিসাবে ট্যাগ করুন!
|